Condor Capital Management’s Bellevue Life Sciences Acquisition Corp. Unit BLACU Stock Holding History

Condor Capital Management’s Portfolio BLACU Stock Details BLACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,600	Closed	-$112K	–	213
2023 Q3	$112K	Hold	10,600	–	–	0.01%	173
2023 Q2	$111K	Sell	10,600 -3,000	-22%	-$31.3K	0.01%	180
2023 Q1	$140K	Buy	+13,600	New	+$139K	0.02%	185

Other funds holding BLACU

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Condor Capital Management's BLACU Position: Q4 2023 in Review

Condor Capital Management sold out of Bellevue Life Sciences Acquisition Corp. Unit (BLACU) in Q4 2023, closing a stake of 10,600 shares — an estimated $112K sold.

Condor Capital Management first reported a position in BLACU in Q1 2023 and held it in 3 quarters. The position peaked at $140K in Q1 2023. 2 funds tracked by Wall St. Rank hold BLACU as of Q4 2023.

Condor Capital Management reported no remaining Bellevue Life Sciences Acquisition Corp. Unit position as of Q4 2023 after selling out during the quarter.
Condor Capital Management sold 10,600 Bellevue Life Sciences Acquisition Corp. Unit shares in Q4 2023, an estimated $112K.
Condor Capital Management first reported a position in Bellevue Life Sciences Acquisition Corp. Unit in Q1 2023 and held it in 3 quarters.
Condor Capital Management's Bellevue Life Sciences Acquisition Corp. Unit position peaked at $140K in Q1 2023.
2 funds tracked by Wall St. Rank held Bellevue Life Sciences Acquisition Corp. Unit as of Q4 2023.

Based on Condor Capital Management's 13F filing for Q4 2023, filed 12 Feb 2024.